135
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Incidence of Metabolic Syndrome and Its Risk Factors in Elderly with Nonalcoholic Fatty Liver Disease

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2835-2842 | Received 14 Jun 2023, Accepted 12 Sep 2023, Published online: 15 Sep 2023

References

  • Noubiap JJ, Richie Nansseu JR, Lontchi-Yimagou E, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924. doi:10.1016/j.diabres.2022.109924
  • Thuyen TQ, Duong DH, Nga BTT, et al. Incidence and prediction nomogram for metabolic syndrome in a middle-aged Vietnamese population: a 5-year follow-up study. Endocr. 2022;75(1):108–118. doi:10.1007/s12020-021-02836-5
  • Farmanfarma K, Ansari-Moghaddam A, Kaykhaei M, Mohammadi M, Adineh H, Aliabd H. Incidence of and factors associated with metabolic syndrome, south-east Islamic Republic of Iran. East Mediterr Health J. 2021;27(11):1084–1091. doi:10.26719/emhj.21.051
  • Hwang JH, Kam S, Shin JY, et al. Incidence of metabolic syndrome and relative importance of five components as a predictor of metabolic syndrome: 5-year follow-up study in Korea. J Korean Med Sci. 2013;28(12):1768–1773. doi:10.3346/jkms.2013.28.12.1768
  • Yang FY, Wahlqvist ML, Lee MS. Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002. Asia Pac J Clin Nutr. 2008;17(2):339–351.
  • Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163(4):427–436. doi:10.1001/archinte.163.4.427
  • Ryan AS. Insulin resistance with aging: effects of diet and exercise. Sports Med. 2000;30(5):327–346. doi:10.2165/00007256-200030050-00002
  • Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Meza-Rios A, et al. Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge. Cells. 2021;10(3):629. doi:10.3390/cells10030629
  • Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis. 2017;14:E24. doi:10.5888/pcd14.160287
  • Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–2411. doi:10.2337/dc12-0336
  • Ge H, Yang Z, Li X, et al. The prevalence and associated factors of metabolic syndrome in Chinese aging population. Sci Rep. 2020;10(1):20034. doi:10.1038/s41598-020-77184-x
  • García-Compeán D, Jiménez-Rodríguez AR. NAFLD VS MAFLD. The evidence-based debate has come. Time to change? Ann Hepatol. 2022;27(6):100765. doi:10.1016/j.aohep.2022.100765
  • Alkagiet S, Papagiannis A, Tziomalos K. Associations between nonalcoholic fatty liver disease and ischemic stroke. World J Hepatol. 2018;10(7):474–478. doi:10.4254/wjh.v10.i7.474
  • Gutiérrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases. Int J Mol Sci. 2021;22(21):11629. doi:10.3390/ijms222111629
  • Golabi P, Paik J, Reddy R, Bugianesi E, Trimble G, Younossi ZM. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol. 2019;19(1):56. doi:10.1186/s12876-019-0972-6
  • Health Promotion Administration, Ministry of Health and Welfare. Taiwan’s Obesity Prevention and Management Strategy. 1st ed. Health Promotion Administration, Ministry of Health and Welfare; 2018:55.
  • Gan L, Chitturi S, Farrell GC. Mechanisms and implications of age-related changes in the liver: nonalcoholic fatty liver disease in the elderly. Curr Gerontol Geriatr Res. 2011;2011:831536. doi:10.1155/2011/831536
  • Wang Z, Xu M, Peng J, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Exp Gerontol. 2013;48(8):705–709. doi:10.1016/j.exger.2013.05.059
  • Ortiz-Rodríguez MA, Yáñez-Velasco L, Carnevale A, et al. Prevalence of metabolic syndrome among elderly Mexicans. Arch Gerontol Geriatr. 2017;73:288–293. doi:10.1016/j.archger.2017.09.001
  • Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z
  • Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol. 2009;8:18–24. doi:10.1016/S1665-2681(19)31822-8
  • Kagansky N, Levy S, Keter D, et al. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients. Liver Int. 2004;24(6):588–594. doi:10.1111/j.1478-3231.2004.0969.x
  • Fan JG, Zhu J, Li XJ, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005;43(3):508–514. doi:10.1016/j.jhep.2005.02.042
  • Bertolotti M, Lonardo A, Mussi C, et al. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol. 2014;20(39):14185–14204. doi:10.3748/wjg.v20.i39.14185
  • Bakhshayeshkaram M, Heydari ST, Honarvar B, et al. Incidence of metabolic syndrome and determinants of its progression in Southern Iran: a 5-year longitudinal follow-up study. J Res Med Sci. 2020;25(1):103. doi:10.4103/jrms.JRMS_884_19
  • James M, Varghese TP, Sharma R, Chand S. Association between metabolic syndrome and diabetes mellitus according to international diabetic federation and national cholesterol education program adult treatment panel III criteria: a cross-sectional study. J Diabetes Metab Disord. 2020;19(1):437–443. doi:10.1007/s40200-020-00523-2
  • Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8(4):339–348. doi:10.1016/j.arr.2009.06.001
  • Jayant SS, Gupta R, Rastogi A, et al. Incidence and predictors of metabolic syndrome in Asian-Indians: a 10-year population-based prospective cohort study. Int J Diabetes Dev Ctries. 2023. doi:10.1007/s13410-023-01169-5
  • Palaniappan L, Carnethon MR, Wang Y, et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27(3):788–793. doi:10.2337/diacare.27.3.788
  • Hsiao PJ, Kuo KK, Shin SJ, et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol. 2007;22(12):2118–2123. doi:10.1111/j.1440-1746.2006.04698.x
  • Hermenegildo-López Y, Donat-Vargas C, Sandoval-Insausti H, et al. A higher intake of energy at dinner is associated with incident metabolic syndrome: a prospective cohort study in older adults. Nutrients. 2021;13(9):3035. doi:10.3390/nu13093035
  • Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med. 2010;50(3):99–105. doi:10.1016/j.ypmed.2009.11.011
  • He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. JACC. 2006;47(8):1588–1594. doi:10.1016/j.jacc.2005.11.074
  • Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. Hepatol. 2013;58(5):1007–1019. doi:10.1016/j.jhep.2012.11.021